Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 17.59 Million CAD | -47.08% |
| 2022 | 18.91 Million CAD | -29.96% |
| 2021 | 27 Million CAD | -2.34% |
| 2020 | 27.65 Million CAD | -4.58% |
| 2019 | 28.98 Million CAD | 6.47% |
| 2018 | 27.22 Million CAD | 177.6% |
| 2017 | 9.8 Million CAD | 292.24% |
| 2016 | 2.5 Million CAD | 81.38% |
| 2015 | 1.37 Million CAD | 115.15% |
| 2014 | 640.67 Thousand CAD | 83.01% |
| 2013 | 350.07 Thousand CAD | -18.01% |
| 2012 | 426.99 Thousand CAD | -45.67% |
| 2011 | 785.97 Thousand CAD | 78.48% |
| 2010 | 440.36 Thousand CAD | 167.29% |
| 2009 | 164.75 Thousand CAD | 40.11% |
| 2008 | 117.58 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.16 Million CAD | -44.28% |
| 2024 Q3 | 883.78 Thousand CAD | -80.65% |
| 2024 Q2 | 3.33 Million CAD | 54.1% |
| 2023 Q3 | 3.74 Million CAD | 89.12% |
| 2023 Q2 | 1.98 Million CAD | -56.52% |
| 2023 Q1 | 4.55 Million CAD | 2.98% |
| 2023 FY | 10.01 Million CAD | -47.08% |
| 2023 Q4 | 3.88 Million CAD | 3.83% |
| 2022 Q4 | 4.42 Million CAD | -14.85% |
| 2022 Q2 | 4.4 Million CAD | -25.99% |
| 2022 Q1 | 5.95 Million CAD | -17.22% |
| 2022 FY | 18.91 Million CAD | -29.96% |
| 2022 Q3 | 5.19 Million CAD | 17.92% |
| 2021 Q4 | 7.19 Million CAD | 6.45% |
| 2021 Q2 | 6.5 Million CAD | -0.99% |
| 2021 Q1 | 6.56 Million CAD | -4.61% |
| 2021 FY | 27 Million CAD | -2.34% |
| 2021 Q3 | 6.75 Million CAD | 3.91% |
| 2020 Q2 | 5.89 Million CAD | -19.63% |
| 2020 Q1 | 7.33 Million CAD | 306.68% |
| 2020 Q3 | 6.7 Million CAD | 13.72% |
| 2020 Q4 | 6.88 Million CAD | 2.67% |
| 2020 FY | 27.65 Million CAD | -4.58% |
| 2019 Q3 | 10.95 Million CAD | 11.9% |
| 2019 Q1 | 11.78 Million CAD | -18.29% |
| 2019 Q2 | 9.79 Million CAD | -16.89% |
| 2019 Q4 | -3.54 Million CAD | -132.38% |
| 2019 FY | 28.98 Million CAD | 6.47% |
| 2018 Q1 | 5.19 Million CAD | 10.01% |
| 2018 FY | 27.22 Million CAD | 177.6% |
| 2018 Q4 | 14.41 Million CAD | 53.94% |
| 2018 Q3 | 9.36 Million CAD | 8.26% |
| 2018 Q2 | 8.65 Million CAD | 66.57% |
| 2017 Q2 | 4.96 Million CAD | 108.38% |
| 2017 Q1 | 2.38 Million CAD | 52.64% |
| 2017 FY | 9.8 Million CAD | 292.24% |
| 2017 Q4 | 4.72 Million CAD | 99.6% |
| 2017 Q3 | 2.36 Million CAD | -52.34% |
| 2016 Q4 | 1.56 Million CAD | 47.63% |
| 2016 Q2 | 683.14 Thousand CAD | 101.12% |
| 2016 FY | 2.5 Million CAD | 81.38% |
| 2016 Q1 | 339.66 Thousand CAD | 477.06% |
| 2016 Q3 | 1.05 Million CAD | 54.72% |
| 2015 FY | 1.37 Million CAD | 115.15% |
| 2015 Q4 | 58.86 Thousand CAD | 114.23% |
| 2015 Q3 | 27.47 Thousand CAD | -42.56% |
| 2015 Q2 | 47.83 Thousand CAD | -71.16% |
| 2015 Q1 | 165.84 Thousand CAD | 27.77% |
| 2014 Q4 | 129.79 Thousand CAD | -39.77% |
| 2014 FY | 640.67 Thousand CAD | 83.01% |
| 2014 Q3 | 215.5 Thousand CAD | -19.96% |
| 2014 Q1 | 187.82 Thousand CAD | 572.43% |
| 2014 Q2 | 269.23 Thousand CAD | 43.35% |
| 2013 Q4 | 27.93 Thousand CAD | -59.32% |
| 2013 FY | 350.07 Thousand CAD | -18.01% |
| 2013 Q1 | 84.27 Thousand CAD | 4.73% |
| 2013 Q2 | 65.65 Thousand CAD | -22.09% |
| 2013 Q3 | 68.66 Thousand CAD | 4.59% |
| 2012 Q4 | 80.46 Thousand CAD | -29.17% |
| 2012 Q1 | 223.31 Thousand CAD | 18.72% |
| 2012 FY | 426.99 Thousand CAD | -45.67% |
| 2012 Q3 | 113.61 Thousand CAD | -23.56% |
| 2012 Q2 | 148.63 Thousand CAD | -33.44% |
| 2011 Q1 | 233.91 Thousand CAD | 348.31% |
| 2011 Q3 | 236.17 Thousand CAD | 70.67% |
| 2011 FY | 785.97 Thousand CAD | 78.48% |
| 2011 Q2 | 138.38 Thousand CAD | -40.84% |
| 2011 Q4 | 188.09 Thousand CAD | -20.36% |
| 2010 FY | 440.36 Thousand CAD | 167.29% |
| 2010 Q3 | 89.39 Thousand CAD | 37.78% |
| 2010 Q2 | 64.87 Thousand CAD | 11.94% |
| 2010 Q1 | 57.95 Thousand CAD | 53.09% |
| 2010 Q4 | 52.17 Thousand CAD | -41.63% |
| 2009 FY | 164.75 Thousand CAD | 40.11% |
| 2009 Q3 | 43.59 Thousand CAD | 72.08% |
| 2009 Q4 | 37.85 Thousand CAD | -13.17% |
| 2009 Q2 | 25.33 Thousand CAD | -90.25% |
| 2009 Q1 | 259.8 Thousand CAD | 207.12% |
| 2008 FY | 117.58 Thousand CAD | 0.0% |
| 2008 Q4 | -242.55 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -493.61% |
| CanadaBis Capital Inc. | 7.1 Million CAD | -147.57% |
| Decibel Cannabis Company Inc. | 40.44 Million CAD | 56.5% |
| Delivra Health Brands Inc. | 7.1 Million CAD | -147.493% |
| Entourage Health Corp. | 3.7 Million CAD | -374.534% |
| Cannara Biotech Inc. | 15.34 Million CAD | -14.674% |
| Medicure Inc. | 13.98 Million CAD | -25.772% |
| PharmaCielo Ltd. | 8.33 Million CAD | -111.163% |
| Rubicon Organics Inc. | 14.22 Million CAD | -23.692% |
| BioSyent Inc. | 17.6 Million CAD | 0.08% |
| Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -1341.03% |